Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That was me trying a small sell at .139 but nada.
If so, you won't hear me complaining!
TGIF AMFE
I was able to buy but my sell test did not go through. Maybe we can run this up just on buys today?
All locked up, and tucked in safe and sound. I'll wake them up when we reach our destination...NASDAQ
Mine are all locked up from the goon gang games. Just put a 60 day for $1.00+. It's that easy. Another stock I have was short attacked bad yesterday with stop losses breaking all day long. Pathetic stuff but uplist cometh...Hoping to get me some more of this gem today.
Yes, we are audited:
otcmarkets.com/stock/DIRV/profile
( RXMD ) SeeThruEquity Issues Update on Progressive Care, Inc.
8:16 AM ET 3/9/18 | Dow Jones
NEW YORK, NY / ACCESSWIRE / March 9, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has issued an update on Progressive Care, Inc. (OTCQB: RXMD).
The report is available here: RXMD June 2016 Update.
Progressive Care, Inc. (OTCQB: RXMD, "Progressive Care") is a health services and technology company based in Miami, FL. Through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, the company provides a range of health services including administration and practice management, utilization management, quality assurance, Electronic Health Records (HER) EHR implementation, billing and coding, health practice risk management, prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), and the supply of prescription medications to long-term care facilities. The company also provides tele-pharmacy services under the name Tele-Pharmco.
Highlights from the update include:
-- Progressive Care has taken significant strides since the last update
issued by SeeThruEquity on the company, with the business eclipsing $20mn
in revenues in 2017 and several new initiatives intended to drive growth
and improve operations in the future. Highlights include:
Increasing price target to $0.35 for RXMD
We are increasing our price target for RXMD at this time to $0.35 per share. Shares eclipsed our prior target of $0.10, as the company has continued to grow and execute in a challenging and competitive environment since our last update, with 2016 revenues of $18.3mn and 2017 revenues confirmed at above $20mn by the company in January. In the interim, the company has achieved multiple corporate objectives, including an uplisting to the OTCQB and the resumption of plans to expand its pharmacy operations to additional states. We see RXMD as an attractive growth story in the healthcare sector applying an innovative approach to the pharmacy business. It is also worth pointing out that healthcare and related companies offer some shielding against factors affecting the broader markets - given the important role of regulation and industry-specific. We would think this would be true for RXMD as well, if it is able to continue to execute on its business objectives and show continued growth.
Please review important disclosures at www.seethruequity.com.
About Progressive Care, Inc.
Progressive Care, Inc. (OTCQB: RXMD, "Progressive Care") is a health services and technology company based in Miami, FL. Through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, the company provides a range of health services including administration and practice management, utilization management, quality assurance, Electronic Health Records (HER) EHR implementation, billing and coding, health practice risk management, prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), and the supply of prescription medications to long term care facilities. The company also provides tele-pharmacy services under the name Tele-Pharmco.
For more information, please visit the company's website at www.progressivecareus.com.
About SeeThruEquity
Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed smallcap and microcap equities. SeeThruEquity has pioneered an innovative business model for equity research that is not paid for and is unbiased. SeeThruEquity is the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than $1 billion.
SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on Wall Street, as well as Capital IQ and FactSet. SeeThruEquity maintains one of the industry's most extensive databases of opt-in institutional and high net worth investors. The firm is headquartered in Midtown Manhattan in New York City.
For more information visit www.seethruequity.com.
Contact:
SeeThruEquity
info@seethruequity.com
SOURCE: SeeThruEquity
> Dow Jones Newswires
March 09, 2018 08:16 ET (13:16 GMT)
Seeing news on eTrade.
Appreciate all of your DD, and fortitude Rocket. Slowly/quietly building a nice position in AMFE. Finger on the trigger for more on what's to come...
PTOP Rising strong and steady...
17k more added to these long and strong hands! Thank you to the non-believers.
Cheers to that Tuna. Good day in the market for some MMJ and AMFE.
Yeah, still have some over there in case but the bulk of my basket is filled up with AMFE. Great things underway here and just over the horizon.
Agreed, I'm here to stay. Love those four letters: AMFE & it's inevitable potential.
Could be a few people transferring some toward another stock that begins with OWC. New interest in that play lately.
e*Trade pro is running fine for me but the website is saying "too busy"!
Thanks much Tuna. Been following along for a while. Started investing in $AMFE since 0.018. Ready for the uplist...
E*trade also showing 664.5 mil OS
I couldn't just sit by and watch those sells take us down the start of the week!
Monday should be glorious.
Primed to move up with little volume!!!
POWER HOUR PUSH!!!
Just need some buyers. I'm tapped out!
SNMN dipping before the RIPPING!
Did a few as well limit @.152 filled @.1507
But it totally upsets my investment strategy that I have followed for years:
1,000 shares per Twitter follower
5,000 shares per facebook follower
10,000 shares per youtube video
1,000,000 per pornhub video
needless to say I'm broke now!!
hahahahahah
Thanks for all of the great DD Rocket. Loving AMFE long and strong...
WEEEEEEEEE!!!!!!!
Never understood the "buy on rumor, sell on news" motto!!! Seems OTC is geared toward flipping and not actual investing.
On another board I follow, a certain someone posted a video chart one night and the next day the stock tanked!!!???
So does Beam_Me_Up! I guess no news is good news for BTCS[D].
The rising price of actual Bitcoins is most likely driving it. I've seen this twice in the recent past. Spikes didn't hold as it is not directly related to what the company has going on (if anything).
My 6mil shares turned into 100k which I promptly sold most of after the RS. Keeping my eye on BTCS but really needs a new business plan.
Just sayin!
On 2/15/17, 60 to 1
My shares gonna carry over to BTCSD or what?
Why?
Pretty much confirms my thoughts from yesterday. Getting all of their ducks in a row, find new investors and acquire, acquire, acquire.
I'm no pro trader but it seems as though they are just clearing up the Spondoolies fiasco. They laid low the second half of 2016 so that they wouldn't hemorrhage due to Spondoolies BK and get dragged down too. Now they can hit the reset button, get all of the paperwork in order and get back to business in 2017!?
Unless I'm reading L2 wrong...looks like MM's are going to keep it right where it is or lower!
If so, and they are converting to a cloud based model as the filings state "other data centers" they could have switched on ten thousand, a million or ten million computers today to run verifications again. With no overhead and a pay per use computer procession model, it could be highly profitable until the next halving at the least.
So ready for this stock to hit warp drive!